Literature DB >> 24059849

Borderline personality symptomatology and legal charges related to drugs.

Randy A Sansone1, Daron A Watts, Michael W Wiederman.   

Abstract

OBJECTIVE: Borderline personality disorder (BPD) is associated with high lifetime prevalence rates of substance abuse as well as higher-than-expected rates of charges for various drug-related crimes and criminal behavior in general. However, whether criminal charges for assault and disorderly conduct are related specifically to drug misuse remains unknown - the focus of the present study.
METHODS: Using a cross-sectional sample and a self-report survey methodology among a sample of 237 consecutive internal medicine outpatients, we examined: (1) BPD symptomatology using two self-report measures and (2) five charges for illegal behaviors defined as related to drugs.
RESULTS: While there were no between-group differences with regard to drug-abuse violations (i.e., possession, sale, or use of illegal drugs), in participants with BPD symptomatology there was more probability to be charged with assault and disorderly conduct related to drug use as well as driving under the influence and drunkenness/public intoxication.
CONCLUSIONS: The criminal behaviors of assault and disorderly conduct observed in BPD appear to be related, at least in part, to comorbid substance abuse.

Entities:  

Keywords:  Borderline personality; Self-Harm Inventory; borderline personality disorder; criminal behavior; illegal behavior; substance abuse

Mesh:

Year:  2013        PMID: 24059849     DOI: 10.3109/13651501.2013.847107

Source DB:  PubMed          Journal:  Int J Psychiatry Clin Pract        ISSN: 1365-1501            Impact factor:   1.812


  2 in total

Review 1.  A Review Study of Substance Abuse Status in High School Students, Isfahan, Iran.

Authors:  Mah Monir Nahvizadeh; Shohreh Akhavan; Sara Arti; Leila Qaraat; Nahid Geramian; Ziba Farajzadegan; Kamal Heidari
Journal:  Int J Prev Med       Date:  2014-12

2.  A retrospective analysis focusing on a group of patients with dual diagnosis treated by both mental health and substance use services.

Authors:  Rosaria Di Lorenzo; Agnese Galliani; Alessia Guicciardi; Giulia Landi; Paola Ferri
Journal:  Neuropsychiatr Dis Treat       Date:  2014-08-11       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.